These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
451 related articles for article (PubMed ID: 32171674)
1. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study. Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674 [TBL] [Abstract][Full Text] [Related]
2. Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial. Advani RH; Hong F; Fisher RI; Bartlett NL; Robinson KS; Gascoyne RD; Wagner H; Stiff PJ; Cheson BD; Stewart DA; Gordon LI; Kahl BS; Friedberg JW; Blum KA; Habermann TM; Tuscano JM; Hoppe RT; Horning SJ J Clin Oncol; 2015 Jun; 33(17):1936-42. PubMed ID: 25897153 [TBL] [Abstract][Full Text] [Related]
3. ABVD or BEACOPP Fermé C; Thomas J; Brice P; Casasnovas O; Vranovsky A; Bologna S; Lugtenburg PJ; Bouabdallah R; Carde P; Sebban C; Eghbali H; Salles G; van Imhoff GW; Thyss A; Noordijk EM; Reman O; Lybeert MLM; Janvier M; Spina M; Audhuy B; Raemaekers JMM; Delarue R; Anglaret B; de Weerdt O; Marjanovic Z; Tersteeg RJHA; de Jong D; Brière J; Henry-Amar M; ; Eur J Cancer; 2017 Aug; 81():45-55. PubMed ID: 28601705 [TBL] [Abstract][Full Text] [Related]
4. Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. Henderson TO; Parsons SK; Wroblewski KE; Chen L; Hong F; Smith SM; McNeer JL; Advani RH; Gascoyne RD; Constine LS; Horning S; Bartlett NL; Shah B; Connors JM; Leonard JI; Kahl BS; Kelly KM; Schwartz CL; Li H; Friedberg JW; Friedman DL; Gordon LI; Evens AM Cancer; 2018 Jan; 124(1):136-144. PubMed ID: 28902390 [TBL] [Abstract][Full Text] [Related]
5. Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial. Russell J; Collins A; Fowler A; Karanth M; Saha C; Docherty S; Padayatty J; Maw K; Lentell I; Cooke L; Hodson A; Shah N; Sadullah S; Grigoropoulos N; Qian W; Kirkwood AA; Uttenthal BJ; Johnson P; Follows GA Ann Hematol; 2021 Apr; 100(4):1049-1058. PubMed ID: 33641019 [TBL] [Abstract][Full Text] [Related]
6. Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma. Skoetz N; Will A; Monsef I; Brillant C; Engert A; von Tresckow B Cochrane Database Syst Rev; 2017 May; 5(5):CD007941. PubMed ID: 28541603 [TBL] [Abstract][Full Text] [Related]
7. Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group. Sasse S; Goergen H; Plütschow A; Böll B; Eichenauer DA; Fuchs M; Behringer K; Zijlstra JM; Greil R; Markova J; Topp MS; Meissner J; Neubauer A; Baues C; Engert A; Borchmann P; von Tresckow B J Clin Oncol; 2018 Sep; 36(25):2603-2611. PubMed ID: 29989855 [TBL] [Abstract][Full Text] [Related]
8. Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades. Koumarianou AA; Xiros N; Papageorgiou E; Pectasides D; Economopoulos T Anticancer Res; 2007; 27(2):1191-7. PubMed ID: 17465262 [TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. Sasse S; Bröckelmann PJ; Goergen H; Plütschow A; Müller H; Kreissl S; Buerkle C; Borchmann S; Fuchs M; Borchmann P; Diehl V; Engert A J Clin Oncol; 2017 Jun; 35(18):1999-2007. PubMed ID: 28418763 [TBL] [Abstract][Full Text] [Related]
10. Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients. Dann EJ; Bairey O; Bar-Shalom R; Mashiach T; Barzilai E; Kornberg A; Akria L; Tadmor T; Filanovsky K; Abadi U; Kagna O; Ruchlemer R; Abdah-Bortnyak R; Goldschmidt N; Epelbaum R; Horowitz NA; Lavie D; Ben-Yehuda D; Shpilberg O; Paltiel O Br J Haematol; 2017 Sep; 178(5):709-718. PubMed ID: 28589704 [TBL] [Abstract][Full Text] [Related]
11. [Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study]. Kochbati L; Fdhila F; Belaid I; Rifi H; Barsaoui S; Ben Romdhane N; Bel Hadj Ali Z; Mezlini A; Oubich F; Maalej M Cancer Radiother; 2012 Oct; 16(7):627-32. PubMed ID: 23084987 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. Merli F; Luminari S; Gobbi PG; Cascavilla N; Mammi C; Ilariucci F; Stelitano C; Musso M; Baldini L; Galimberti S; Angrilli F; Polimeno G; Scalzulli PR; Ferrari A; Marcheselli L; Federico M J Clin Oncol; 2016 Apr; 34(11):1175-81. PubMed ID: 26712220 [TBL] [Abstract][Full Text] [Related]
13. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens. Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149 [TBL] [Abstract][Full Text] [Related]
14. Combined modality treatment: Outcome in patients with Hodgkin's lymphoma. Yadav BS; Sharma SC; Malhotra P; Prakash G J Cancer Res Ther; 2020; 16(1):1-6. PubMed ID: 32362601 [TBL] [Abstract][Full Text] [Related]
15. Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. Eich HT; Diehl V; Görgen H; Pabst T; Markova J; Debus J; Ho A; Dörken B; Rank A; Grosu AL; Wiegel T; Karstens JH; Greil R; Willich N; Schmidberger H; Döhner H; Borchmann P; Müller-Hermelink HK; Müller RP; Engert A J Clin Oncol; 2010 Sep; 28(27):4199-206. PubMed ID: 20713848 [TBL] [Abstract][Full Text] [Related]
16. ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. Gobbi PG; Levis A; Chisesi T; Broglia C; Vitolo U; Stelitano C; Pavone V; Cavanna L; Santini G; Merli F; Liberati M; Baldini L; Deliliers GL; Angelucci E; Bordonaro R; Federico M; J Clin Oncol; 2005 Dec; 23(36):9198-207. PubMed ID: 16172458 [TBL] [Abstract][Full Text] [Related]
17. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118 [TBL] [Abstract][Full Text] [Related]
18. Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis. Skoetz N; Trelle S; Rancea M; Haverkamp H; Diehl V; Engert A; Borchmann P Lancet Oncol; 2013 Sep; 14(10):943-52. PubMed ID: 23948348 [TBL] [Abstract][Full Text] [Related]
19. [Our experiences in treating patients with Hodgkin disease in the last decade]. Simon Z; Keresztes K; Miltényi Z; Ress Z; Váróczy L; Vadász G; Gergely L; Illés A Orv Hetil; 2007 Apr; 148(15):675-82. PubMed ID: 17416575 [TBL] [Abstract][Full Text] [Related]
20. Hodgkin's lymphoma in adolescents. Foltz LM; Song KW; Connors JM J Clin Oncol; 2006 Jun; 24(16):2520-6. PubMed ID: 16735704 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]